Uganda emerges from Covid-19 pandemic with renewed focus on home-grown vaccines


Nick Webster
  • English
  • Arabic

Slow access to vaccines and challenges to administer them across Africa have forced nations to rethink how to deliver healthcare in a new era of global pandemics.

Uganda, in East Africa, recorded one of the lowest death rates from Covid-19 largely due to a stringent 18-month lockdown and a population with an average age of just 17 that meant few were at risk of being admitted to hospitals.

Health officials in the country have been pressed into accelerating plans to become less reliant on foreign aid during times of crisis, such as the Covid pandemic.

It is clear we cannot be at the mercy of Western countries if there is another pandemic. We are now thinking about how we can build capacity for our own survival.
Dr Diane Atwine,
permanent secretary Uganda Ministry of Health

So far, Uganda’s population of 45 million has recorded 164,000 confirmed cases of Covid-19 and 3,594 deaths.

Dr Diane Atwine, permanent secretary at the Ministry of Health, had a major role in planning how to use the country’s resources during the pandemic, and said it has forced Uganda to rethink its national health strategy.

“It took almost a year to start receiving vaccines. Even though we had money, we had to go via the African Union and Covax,” said Dr Atwine, who reported directly to President Yoweri Museveni as head of the national Covid task force.

“Because of this, we had to go with our own home-grown solutions to safeguard the population.

“Our decisions were based on science, including lockdowns.

“We did not want to wait until hundreds were dying and to look at our options. Decisions were made in accordance with risk.

“If we delayed, our health system would be overwhelmed and more lives would be lost.”

Prolonged lockdown in Uganda

Nightly curfews, homeschooling for 16 million children and remote working were mandatory for 18 months.

When the population came blinking into the light in January, Uganda was a different country prepared to embrace a new set of challenges such as access to vaccines.

Around a third of the population (16 million) is protected with two doses.

Although anti-vaccine sentiments are not common, Uganda is planning a new law to fine those refusing to be vaccinated.

A law under parliamentary review proposes a penalty of 4 million Ugandan shillings ($1,140) for those refusing a vaccine. The average wage in Uganda is around $180 a month.

“Our vaccine rate is still low and we have teams in the field to push through second doses and boosters,” said Dr Atwine.

“We don’t have enough vaccines for everyone, so we can’t vaccinate children under 18 yet.

“One of the hindrances of access to care has been a culture of protecting patents for drugs.

“When the pandemic came, it was a big wake-up call.

“Africa and Uganda had been dependent on foreign support. Now we are supporting scientists here to develop our own vaccines.

A woman receives a coronavirus vaccine at the Kololo airstrip in Kampala, Uganda. AP
A woman receives a coronavirus vaccine at the Kololo airstrip in Kampala, Uganda. AP

“Our Uganda Virus Research Institute has been developing our own vaccine, and we will soon have a clinical trial in one of our hospitals.”

Covid-19 vaccine supplies to Africa have risen significantly in recent months, but just 11 per cent of the continent is fully vaccinated.

A 70 per cent target has been set for the second quarter of 2022, but that seems unlikely unless the World Health Organisation, Unicef and the International Federation of Red Cross and Red Crescent Societies can resolve bottlenecks.

So far, Africa has received more than 587 million vaccine doses. Of those, 58 per cent have come through the Covax facility, 36 per cent via bilateral deals and 6 per cent through the African Union.

Uganda seeks home-grown Covid solutions after vaccine shortfall

While Uganda is currently developing its own Covid vaccine, the National Drug Authority has already approved its own antiviral treatment to protect the vulnerable.

Covidex is a locally made herbal remedy to fight virus infections, approved and licensed for sale in pharmacies across the country.

The WHO has not approved the drug, but pharmacists in Uganda said they had few options for viral treatments as other FDA-approved drugs such as molnupiravir, paxlovid and sotrovimab were not widely available.

A 12-day visit by the WHO in March assessed Uganda’s capacity for developing life sciences.

The tour of several sites included potential new areas for pharmaceutical manufacturing that could make the country more self-sufficient in drug production.

“We could not get PPE from China or elsewhere so we set up our own production sites, from sanitisers to masks, to look after our own needs,” said Dr Atwine.

“It is clear we cannot be at the mercy of Western countries if there is another pandemic.

“That has been a big lesson for us.

“Africa is on the move as a continent and we are now thinking how we can build capacity for our own survival.”

Government hospitals provide care to Uganda’s poorest, but services are patchy, leaving many reliant on private health providers and health insurance.

Emergency services are also expensive, with private ambulances charging around $50 to collect patients.

Others unable to pay are reliant on public goodwill to take them into hospital, or the vast network of motorcycle taxis, known as ‘boda-boda’ that cover much of Kampala.

Rise of remote care bringing doctors directly to the door

Evolving healthcare in Uganda has seen the emergence of telehealth services.

As in many nations, improving access to online medical support restricts the need for Ugandans to travel long distances, across poor public transport networks in rural areas to seek care in the city.

It is also considerably cheaper.

A start-up business to emerge strongly from the pandemic is Rocket Health — a remote care provider that offers affordable clinical support from video consultations to artificial intelligence-powered triage.

Rocket Health saw a 500 per cent increase in phone and video consultations in 2020, and a quadrupling of demand in 2021.

“Patients call us and we can either call them back or take the call immediately,” said Dr Sharon Akisa, a GP at Rocket Health.

“An assessment is made for either a prescription or to take a blood sample. They are then processed with results sent to our dashboard.

“We then call the patient back to discuss the next course of action.”

Rocket Health predominantly deals with chronic health conditions that require continuing management, but doctors saw a huge surge in demand during the pandemic for patients with Covid symptoms.

By passing on advice remotely, and delivering medication by motorbike when needed, doctors were able to keep symptomatic patients away from other vulnerable people.

Most doctors have roles in hospitals around Kampala, and complete shifts at Rocket Health to supplement their incomes.

“I joined the company during the second wave of the virus. Phones were constantly ringing and we took around 80 calls a day each,” said Dr Akisa.

“We tried to reach all those we could, and the more serious cases were referred to hospitals.”

Most regular consultations cost between 20,000 and 40,000 shillings ($5-10) in government hospitals, but Rocket Health charges just 10,000 shillings ($2.5).

Private health clinics have not yet been approved to administer Covid-19 vaccines, but they can deliver PCR tests for 145,000 shillings ($40).

Rocket Health can be used via standard-feature phones, so a mobile app on a smartphone is not required.

Users can gain access to a checklist on their mobile phone to indicate symptoms, so they can be triaged virtually and assigned a relevant doctor.

It makes the service more accessible to those living in rural communities or on a low income.

“It is convenient for them, and it means they do not have to come into the clinic or spend money on public transport,” said Betty Nazziwa, Rocket Health lab technician.

People in Africa receive Covid-19 vaccines – in pictures

  • A boy receives a Covid-19 vaccination at a site near Johannesburg. The World Health Organisation's Africa director Matshidiso Moeti says the continent is moving into the ‘control phase’ of the pandemic. AP
    A boy receives a Covid-19 vaccination at a site near Johannesburg. The World Health Organisation's Africa director Matshidiso Moeti says the continent is moving into the ‘control phase’ of the pandemic. AP
  • Vaccinations are prepared at a health centre in Nairobi, Kenya. AP
    Vaccinations are prepared at a health centre in Nairobi, Kenya. AP
  • With masks on, hairdresser Tembi Ndlovu tends to a client in a salon in Harare, Zimbabwe. AP
    With masks on, hairdresser Tembi Ndlovu tends to a client in a salon in Harare, Zimbabwe. AP
  • A health official takes a sample for tests at a private Covid-19 testing centre in Harare. AP
    A health official takes a sample for tests at a private Covid-19 testing centre in Harare. AP
  • A child receives his Pfizer-BioNTech vaccine against Covi-19 in Diepsloot township near Johannesburg. AP
    A child receives his Pfizer-BioNTech vaccine against Covi-19 in Diepsloot township near Johannesburg. AP
  • Martin Lako prepares to vaccinate Timon Buga Kujo in Juba, South Sudan. Reuters
    Martin Lako prepares to vaccinate Timon Buga Kujo in Juba, South Sudan. Reuters
  • A man is tested for Covid-19 in Harare. AP Photo
    A man is tested for Covid-19 in Harare. AP Photo
  • Travellers wait for a coronavirus test at the Gatuna border post at Gicumbi, northern Rwanda. Reuters
    Travellers wait for a coronavirus test at the Gatuna border post at Gicumbi, northern Rwanda. Reuters
  • A man is vaccinated at Wuse market in Abuja, Nigeria. Reuters
    A man is vaccinated at Wuse market in Abuja, Nigeria. Reuters
Match statistics

Abu Dhabi Harlequins 36 Bahrain 32

 

Harlequins

Tries: Penalty 2, Stevenson, Teasdale, Semple

Cons: Stevenson 2

Pens: Stevenson

 

Bahrain

Tries: Wallace 2, Heath, Evans, Behan

Cons: Radley 2

Pen: Radley

 

Man of the match: Craig Nutt (Harlequins)

Sinopharm vaccine explained

The Sinopharm vaccine was created using techniques that have been around for decades. 

“This is an inactivated vaccine. Simply what it means is that the virus is taken, cultured and inactivated," said Dr Nawal Al Kaabi, chair of the UAE's National Covid-19 Clinical Management Committee.

"What is left is a skeleton of the virus so it looks like a virus, but it is not live."

This is then injected into the body.

"The body will recognise it and form antibodies but because it is inactive, we will need more than one dose. The body will not develop immunity with one dose," she said.

"You have to be exposed more than one time to what we call the antigen."

The vaccine should offer protection for at least months, but no one knows how long beyond that.

Dr Al Kaabi said early vaccine volunteers in China were given shots last spring and still have antibodies today.

“Since it is inactivated, it will not last forever," she said.

Springsteen: Deliver Me from Nowhere

Director: Scott Cooper

Starring: Jeremy Allen White, Odessa Young, Jeremy Strong

Rating: 4/5

Who's who in Yemen conflict

Houthis: Iran-backed rebels who occupy Sanaa and run unrecognised government

Yemeni government: Exiled government in Aden led by eight-member Presidential Leadership Council

Southern Transitional Council: Faction in Yemeni government that seeks autonomy for the south

Habrish 'rebels': Tribal-backed forces feuding with STC over control of oil in government territory

Ten tax points to be aware of in 2026

1. Domestic VAT refund amendments: request your refund within five years

If a business does not apply for the refund on time, they lose their credit.

2. E-invoicing in the UAE

Businesses should continue preparing for the implementation of e-invoicing in the UAE, with 2026 a preparation and transition period ahead of phased mandatory adoption. 

3. More tax audits

Tax authorities are increasingly using data already available across multiple filings to identify audit risks. 

4. More beneficial VAT and excise tax penalty regime

Tax disputes are expected to become more frequent and more structured, with clearer administrative objection and appeal processes. The UAE has adopted a new penalty regime for VAT and excise disputes, which now mirrors the penalty regime for corporate tax.

5. Greater emphasis on statutory audit

There is a greater need for the accuracy of financial statements. The International Financial Reporting Standards standards need to be strictly adhered to and, as a result, the quality of the audits will need to increase.

6. Further transfer pricing enforcement

Transfer pricing enforcement, which refers to the practice of establishing prices for internal transactions between related entities, is expected to broaden in scope. The UAE will shortly open the possibility to negotiate advance pricing agreements, or essentially rulings for transfer pricing purposes. 

7. Limited time periods for audits

Recent amendments also introduce a default five-year limitation period for tax audits and assessments, subject to specific statutory exceptions. While the standard audit and assessment period is five years, this may be extended to up to 15 years in cases involving fraud or tax evasion. 

8. Pillar 2 implementation 

Many multinational groups will begin to feel the practical effect of the Domestic Minimum Top-Up Tax (DMTT), the UAE's implementation of the OECD’s global minimum tax under Pillar 2. While the rules apply for financial years starting on or after January 1, 2025, it is 2026 that marks the transition to an operational phase.

9. Reduced compliance obligations for imported goods and services

Businesses that apply the reverse-charge mechanism for VAT purposes in the UAE may benefit from reduced compliance obligations. 

10. Substance and CbC reporting focus

Tax authorities are expected to continue strengthening the enforcement of economic substance and Country-by-Country (CbC) reporting frameworks. In the UAE, these regimes are increasingly being used as risk-assessment tools, providing tax authorities with a comprehensive view of multinational groups’ global footprints and enabling them to assess whether profits are aligned with real economic activity. 

Contributed by Thomas Vanhee and Hend Rashwan, Aurifer

BMW M5 specs

Engine: 4.4-litre twin-turbo V-8 petrol enging with additional electric motor

Power: 727hp

Torque: 1,000Nm

Transmission: 8-speed auto

Fuel consumption: 10.6L/100km

On sale: Now

Price: From Dh650,000

Ferrari 12Cilindri specs

Engine: naturally aspirated 6.5-liter V12

Power: 819hp

Torque: 678Nm at 7,250rpm

Price: From Dh1,700,000

Available: Now

Company%20Profile
%3Cp%3E%3Cstrong%3ECompany%20name%3A%20%3C%2Fstrong%3ENamara%0D%3Cbr%3E%3Cstrong%3EStarted%3A%20%3C%2Fstrong%3EJune%202022%0D%3Cbr%3E%3Cstrong%3EFounder%3A%20%3C%2Fstrong%3EMohammed%20Alnamara%0D%3Cbr%3E%3Cstrong%3EBased%3A%20%3C%2Fstrong%3EDubai%20%0D%3Cbr%3E%3Cstrong%3ESector%3A%20%3C%2Fstrong%3EMicrofinance%0D%3Cbr%3E%3Cstrong%3ECurrent%20number%20of%20staff%3A%20%3C%2Fstrong%3E16%0D%3Cbr%3E%3Cstrong%3EInvestment%20stage%3A%20%3C%2Fstrong%3ESeries%20A%0D%3Cbr%3E%3Cstrong%3EInvestors%3A%20%3C%2Fstrong%3EFamily%20offices%0D%3Cbr%3E%3C%2Fp%3E%0A
The specs
Engine: 3.0-litre 6-cyl turbo

Power: 374hp at 5,500-6,500rpm

Torque: 500Nm from 1,900-5,000rpm

Transmission: 8-speed auto

Fuel consumption: 8.5L/100km

Price: from Dh285,000

On sale: from January 2022 

'The Woman in the House Across the Street from the Girl in the Window'

Director:Michael Lehmann

Stars:Kristen Bell

Rating: 1/5

Updated: March 20, 2022, 6:27 AM